GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
229 hedge funds and large institutions have $3.51B invested in Global Blood Therapeutics, Inc. in 2020 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 91 increasing their positions, 76 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $4.09B → $3.51B (-$590M)
42% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 52
Holders
229
Holding in Top 10
6
Calls
$27.6M
Puts
$30.6M
Top Buyers
| 1 | +$49.1M | |
| 2 | +$48.2M | |
| 3 | +$39.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$37.3M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$33.1M |
Top Sellers
| 1 | -$137M | |
| 2 | -$79.8M | |
| 3 | -$19.4M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$18.6M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$18.2M |